Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1985 1
1987 1
1988 5
1989 8
1990 13
1991 7
1992 7
1993 12
1994 12
1995 5
1996 11
1997 14
1998 10
1999 9
2000 8
2001 16
2002 6
2003 15
2004 10
2005 11
2006 12
2007 11
2008 15
2009 24
2010 28
2011 27
2012 20
2013 24
2014 25
2015 49
2016 39
2017 51
2018 55
2019 53
2020 57
2021 74
2022 51
2023 61
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

789 results

Results by year

Filters applied: . Clear all
Page 1
International Consensus Classification of acute lymphoblastic leukemia/lymphoma.
Duffield AS, Mullighan CG, Borowitz MJ. Duffield AS, et al. Virchows Arch. 2023 Jan;482(1):11-26. doi: 10.1007/s00428-022-03448-8. Epub 2022 Nov 24. Virchows Arch. 2023. PMID: 36422706 Free PMC article. Review.
The updated International Consensus Classification (ICC) of B-acute lymphoblastic leukemia (B-ALL) and T-acute lymphoblastic leukemia (T-ALL) includes both revisions to subtypes previously outlined in the 2016 WHO classification and sever …
The updated International Consensus Classification (ICC) of B-acute lymphoblastic leukemia (B-ALL) and T-acute
Pediatric acute lymphoblastic leukemia.
Inaba H, Mullighan CG. Inaba H, et al. Haematologica. 2020 Nov 1;105(11):2524-2539. doi: 10.3324/haematol.2020.247031. Haematologica. 2020. PMID: 33054110 Free PMC article. Review.
The last decade has witnessed great advances in our understanding of the genetic and biological basis of childhood acute lymphoblastic leukemia (ALL), the development of experimental models to probe mechanisms and evaluate new therapies, and the develo …
The last decade has witnessed great advances in our understanding of the genetic and biological basis of childhood acute ly
Inotuzumab ozogamicin in B-cell precursor acute lymphoblastic leukemia: efficacy, toxicity, and practical considerations.
Rubinstein JD, O'Brien MM. Rubinstein JD, et al. Front Immunol. 2023 Aug 3;14:1237738. doi: 10.3389/fimmu.2023.1237738. eCollection 2023. Front Immunol. 2023. PMID: 37600823 Free PMC article. Review.
InO has shown significant activity in relapsed and refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in both single agent and combination chemotherapy regimens in adult and pediatric trials. ...Notable toxicities include …
InO has shown significant activity in relapsed and refractory B-cell precursor acute lymphoblastic leu
Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.
Lejman M, Chałupnik A, Chilimoniuk Z, Dobosz M. Lejman M, et al. Int J Mol Sci. 2022 Mar 2;23(5):2755. doi: 10.3390/ijms23052755. Int J Mol Sci. 2022. PMID: 35269896 Free PMC article. Review.
Acute lymphoblastic leukemia (ALL) is a heterogeneous group of hematologic malignancies characterized by abnormal proliferation of immature lymphoid cells. ...In this article, we provide an overview of the latest information on genomic alterations found in
Acute lymphoblastic leukemia (ALL) is a heterogeneous group of hematologic malignancies characterized by abnormal proli
Acute lymphoblastic leukemia: a comprehensive review and 2017 update.
Terwilliger T, Abdul-Hay M. Terwilliger T, et al. Blood Cancer J. 2017 Jun 30;7(6):e577. doi: 10.1038/bcj.2017.53. Blood Cancer J. 2017. PMID: 28665419 Free PMC article. Review.
Acute lymphoblastic leukemia (ALL) is the second most common acute leukemia in adults, with an incidence of over 6500 cases per year in the United States alone. The hallmark of ALL is chromosomal abnormalities and genetic alterations involved in
Acute lymphoblastic leukemia (ALL) is the second most common acute leukemia in adults, with an incidence
Update on Lymphoblastic Leukemia/Lymphoma.
Luca DC. Luca DC. Clin Lab Med. 2021 Sep;41(3):405-416. doi: 10.1016/j.cll.2021.04.003. Clin Lab Med. 2021. PMID: 34304772 Review.
Lymphoblastic leukemias/lymphomas are predominantly diseases of childhood, where they represent almost all acute leukemias; however, they are also encountered with significant frequency in the adult population. These neoplastic processes can be of B-
Lymphoblastic leukemias/lymphomas are predominantly diseases of childhood, where they represent almost all acute leukem
The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades.
Jabbour E, Short NJ, Jain N, Haddad FG, Welch MA, Ravandi F, Kantarjian H. Jabbour E, et al. J Hematol Oncol. 2023 Mar 16;16(1):22. doi: 10.1186/s13045-023-01409-5. J Hematol Oncol. 2023. PMID: 36927623 Free PMC article. Review.
Progress in the research and therapy of adult acute lymphoblastic leukemia (ALL) is accelerating. This analysis summarizes the data derived from the clinical trials conducted at MD Anderson between 1985 and 2022 across ALL subtypes. ...Among patients 65-70 ye …
Progress in the research and therapy of adult acute lymphoblastic leukemia (ALL) is accelerating. This analysis summari …
Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia.
Kruse A, Abdel-Azim N, Kim HN, Ruan Y, Phan V, Ogana H, Wang W, Lee R, Gang EJ, Khazal S, Kim YM. Kruse A, et al. Int J Mol Sci. 2020 Feb 5;21(3):1054. doi: 10.3390/ijms21031054. Int J Mol Sci. 2020. PMID: 32033444 Free PMC article. Review.
Minimal residual disease (MRD) refers to a chemotherapy/radiotherapy-surviving leukemia cell population that gives rise to relapse of the disease. ...
Minimal residual disease (MRD) refers to a chemotherapy/radiotherapy-surviving leukemia cell population that gives rise to rel …
B Cell Lymphoma.
Meng X, Min Q, Wang JY. Meng X, et al. Adv Exp Med Biol. 2020;1254:161-181. doi: 10.1007/978-981-15-3532-1_12. Adv Exp Med Biol. 2020. PMID: 32323276 Review.
B cell development and activation are accompanied by dynamic genetic alterations including V(D)J rearrangements and immunoglobulin-gene somatic hypermutation and class-switch recombination. ...In fact, B cell lymphoma accounts for 95% of the lymphomas.
B cell development and activation are accompanied by dynamic genetic alterations including V(D)J rearrangements and immunoglob
Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K, Sheikh T, Aggarwal N. Davis K, et al. Semin Diagn Pathol. 2023 May;40(3):202-215. doi: 10.1053/j.semdp.2023.04.003. Epub 2023 Apr 9. Semin Diagn Pathol. 2023. PMID: 37120350 Review.
Tremendous strides have been made in the molecular and cytogenetic classification of acute lymphoblastic leukemia based on gene expression profiling data, leading to an expansion of entities in the recent International Consensus Classification (ICC) of myeloi …
Tremendous strides have been made in the molecular and cytogenetic classification of acute lymphoblastic leukemia based …
789 results